#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Bret Coldren Email
VP, Formulation and Delivery Sciences, Gene Editing . Ionis Pharmaceuticals
Carlsbad, CA
LocationPrimary Email
How to contact Bret Coldren
Join and see Bret's contact info for free!Phone
Current Roles
Employees:
945Revenue:
$660.7MAbout
As the leader in RNA-targeted drug discovery and development, Ionis has created an efficient, broadly applicable, proprietary antisense technology platform with the potential to treat diseases where no other therapeutic approaches have proven effective. Our drug discovery platform has served as a springboard for actionable promise and realized hope for patients with unmet needs such as children and adults with spinal muscular atrophy (SMA). We created SPINRAZA® (nusinersen)* and are proud to have brought new hope to the SMA community by developing the first and only approved treatment for this disease. Our sights are set on all the patients we have yet to reach with a pipeline of more than 40 drugs with the potential to treat patients with cardiovascular disease, rare diseases, neurological diseases, infectious diseases and cancer. We created TEGSEDI (inotersen) the world's first RNA-targeted therapeutic approved for the treatment of stage 1 or stage 2 polyneuropathy in adult patients with hereditary transthyretin (TTR) amyloidosis (ATTR) that our affiliate Akcea Therapeutics is commercializing. Together with Akcea, we are also bringing new medicines to patients with cardiometabolic lipid disorders. To learn more about Ionis follow us on twitter @ionispharma or visit http://ir.ionispharma.com/. *Spinraza is marketed by Biogen.Ionis Pharmaceuticals Address
2855 Gazelle CourtCarlsbad, CA
United States